Links to Exploration step
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Patient-Reported Outcomes in Sentinel Node–Negative Adjuvant Breast Cancer Patients Receiving Sentinel-Node Biopsy or Axillary Dissection: National Surgical Adjuvant Breast and Bowel Project Phase III Protocol B-32</title><author><name sortKey="Land, Stephanie R" sort="Land, Stephanie R" uniqKey="Land S" first="Stephanie R." last="Land">Stephanie R. Land</name><affiliation><nlm:aff id="aff1">From the National Surgical Adjuvant Breast and Bowel Project Operations and Biostatistics Center; Graduate School of Public Health, University of Pittsburgh; Allegheny General Hospital, Pittsburgh, PA; Arthritis Research Center of Canada, University of British Columbia, Vancouver, British Columbia, Canada; University of Vermont College of Medicine; University of Vermont Breast Care Center, United Health Care, Burlington, VT; and the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA.</nlm:aff></affiliation></author><author><name sortKey="Kopec, Jacek A" sort="Kopec, Jacek A" uniqKey="Kopec J" first="Jacek A." last="Kopec">Jacek A. Kopec</name><affiliation><nlm:aff id="aff1">From the National Surgical Adjuvant Breast and Bowel Project Operations and Biostatistics Center; Graduate School of Public Health, University of Pittsburgh; Allegheny General Hospital, Pittsburgh, PA; Arthritis Research Center of Canada, University of British Columbia, Vancouver, British Columbia, Canada; University of Vermont College of Medicine; University of Vermont Breast Care Center, United Health Care, Burlington, VT; and the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA.</nlm:aff></affiliation></author><author><name sortKey="Julian, Thomas B" sort="Julian, Thomas B" uniqKey="Julian T" first="Thomas B." last="Julian">Thomas B. Julian</name><affiliation><nlm:aff id="aff1">From the National Surgical Adjuvant Breast and Bowel Project Operations and Biostatistics Center; Graduate School of Public Health, University of Pittsburgh; Allegheny General Hospital, Pittsburgh, PA; Arthritis Research Center of Canada, University of British Columbia, Vancouver, British Columbia, Canada; University of Vermont College of Medicine; University of Vermont Breast Care Center, United Health Care, Burlington, VT; and the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA.</nlm:aff></affiliation></author><author><name sortKey="Brown, Ann M" sort="Brown, Ann M" uniqKey="Brown A" first="Ann M." last="Brown">Ann M. Brown</name><affiliation><nlm:aff id="aff1">From the National Surgical Adjuvant Breast and Bowel Project Operations and Biostatistics Center; Graduate School of Public Health, University of Pittsburgh; Allegheny General Hospital, Pittsburgh, PA; Arthritis Research Center of Canada, University of British Columbia, Vancouver, British Columbia, Canada; University of Vermont College of Medicine; University of Vermont Breast Care Center, United Health Care, Burlington, VT; and the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA.</nlm:aff></affiliation></author><author><name sortKey="Anderson, Stewart J" sort="Anderson, Stewart J" uniqKey="Anderson S" first="Stewart J." last="Anderson">Stewart J. Anderson</name><affiliation><nlm:aff id="aff1">From the National Surgical Adjuvant Breast and Bowel Project Operations and Biostatistics Center; Graduate School of Public Health, University of Pittsburgh; Allegheny General Hospital, Pittsburgh, PA; Arthritis Research Center of Canada, University of British Columbia, Vancouver, British Columbia, Canada; University of Vermont College of Medicine; University of Vermont Breast Care Center, United Health Care, Burlington, VT; and the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA.</nlm:aff></affiliation></author><author><name sortKey="Krag, David N" sort="Krag, David N" uniqKey="Krag D" first="David N." last="Krag">David N. Krag</name><affiliation><nlm:aff id="aff1">From the National Surgical Adjuvant Breast and Bowel Project Operations and Biostatistics Center; Graduate School of Public Health, University of Pittsburgh; Allegheny General Hospital, Pittsburgh, PA; Arthritis Research Center of Canada, University of British Columbia, Vancouver, British Columbia, Canada; University of Vermont College of Medicine; University of Vermont Breast Care Center, United Health Care, Burlington, VT; and the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA.</nlm:aff></affiliation></author><author><name sortKey="Christian, Nicholas J" sort="Christian, Nicholas J" uniqKey="Christian N" first="Nicholas J." last="Christian">Nicholas J. Christian</name><affiliation><nlm:aff id="aff1">From the National Surgical Adjuvant Breast and Bowel Project Operations and Biostatistics Center; Graduate School of Public Health, University of Pittsburgh; Allegheny General Hospital, Pittsburgh, PA; Arthritis Research Center of Canada, University of British Columbia, Vancouver, British Columbia, Canada; University of Vermont College of Medicine; University of Vermont Breast Care Center, United Health Care, Burlington, VT; and the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA.</nlm:aff></affiliation></author><author><name sortKey="Costantino, Joseph P" sort="Costantino, Joseph P" uniqKey="Costantino J" first="Joseph P." last="Costantino">Joseph P. Costantino</name><affiliation><nlm:aff id="aff1">From the National Surgical Adjuvant Breast and Bowel Project Operations and Biostatistics Center; Graduate School of Public Health, University of Pittsburgh; Allegheny General Hospital, Pittsburgh, PA; Arthritis Research Center of Canada, University of British Columbia, Vancouver, British Columbia, Canada; University of Vermont College of Medicine; University of Vermont Breast Care Center, United Health Care, Burlington, VT; and the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA.</nlm:aff></affiliation></author><author><name sortKey="Wolmark, Norman" sort="Wolmark, Norman" uniqKey="Wolmark N" first="Norman" last="Wolmark">Norman Wolmark</name><affiliation><nlm:aff id="aff1">From the National Surgical Adjuvant Breast and Bowel Project Operations and Biostatistics Center; Graduate School of Public Health, University of Pittsburgh; Allegheny General Hospital, Pittsburgh, PA; Arthritis Research Center of Canada, University of British Columbia, Vancouver, British Columbia, Canada; University of Vermont College of Medicine; University of Vermont Breast Care Center, United Health Care, Burlington, VT; and the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA.</nlm:aff></affiliation></author><author><name sortKey="Ganz, Patricia A" sort="Ganz, Patricia A" uniqKey="Ganz P" first="Patricia A." last="Ganz">Patricia A. Ganz</name><affiliation><nlm:aff id="aff1">From the National Surgical Adjuvant Breast and Bowel Project Operations and Biostatistics Center; Graduate School of Public Health, University of Pittsburgh; Allegheny General Hospital, Pittsburgh, PA; Arthritis Research Center of Canada, University of British Columbia, Vancouver, British Columbia, Canada; University of Vermont College of Medicine; University of Vermont Breast Care Center, United Health Care, Burlington, VT; and the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA.</nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">20679600</idno><idno type="pmc">2940391</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2940391</idno><idno type="RBID">PMC:2940391</idno><idno type="doi">10.1200/JCO.2010.28.2491</idno><date when="2010">2010</date><idno type="wicri:Area/Pmc/Corpus">002F37</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">002F37</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Patient-Reported Outcomes in Sentinel Node–Negative Adjuvant Breast Cancer Patients Receiving Sentinel-Node Biopsy or Axillary Dissection: National Surgical Adjuvant Breast and Bowel Project Phase III Protocol B-32</title><author><name sortKey="Land, Stephanie R" sort="Land, Stephanie R" uniqKey="Land S" first="Stephanie R." last="Land">Stephanie R. Land</name><affiliation><nlm:aff id="aff1">From the National Surgical Adjuvant Breast and Bowel Project Operations and Biostatistics Center; Graduate School of Public Health, University of Pittsburgh; Allegheny General Hospital, Pittsburgh, PA; Arthritis Research Center of Canada, University of British Columbia, Vancouver, British Columbia, Canada; University of Vermont College of Medicine; University of Vermont Breast Care Center, United Health Care, Burlington, VT; and the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA.</nlm:aff></affiliation></author><author><name sortKey="Kopec, Jacek A" sort="Kopec, Jacek A" uniqKey="Kopec J" first="Jacek A." last="Kopec">Jacek A. Kopec</name><affiliation><nlm:aff id="aff1">From the National Surgical Adjuvant Breast and Bowel Project Operations and Biostatistics Center; Graduate School of Public Health, University of Pittsburgh; Allegheny General Hospital, Pittsburgh, PA; Arthritis Research Center of Canada, University of British Columbia, Vancouver, British Columbia, Canada; University of Vermont College of Medicine; University of Vermont Breast Care Center, United Health Care, Burlington, VT; and the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA.</nlm:aff></affiliation></author><author><name sortKey="Julian, Thomas B" sort="Julian, Thomas B" uniqKey="Julian T" first="Thomas B." last="Julian">Thomas B. Julian</name><affiliation><nlm:aff id="aff1">From the National Surgical Adjuvant Breast and Bowel Project Operations and Biostatistics Center; Graduate School of Public Health, University of Pittsburgh; Allegheny General Hospital, Pittsburgh, PA; Arthritis Research Center of Canada, University of British Columbia, Vancouver, British Columbia, Canada; University of Vermont College of Medicine; University of Vermont Breast Care Center, United Health Care, Burlington, VT; and the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA.</nlm:aff></affiliation></author><author><name sortKey="Brown, Ann M" sort="Brown, Ann M" uniqKey="Brown A" first="Ann M." last="Brown">Ann M. Brown</name><affiliation><nlm:aff id="aff1">From the National Surgical Adjuvant Breast and Bowel Project Operations and Biostatistics Center; Graduate School of Public Health, University of Pittsburgh; Allegheny General Hospital, Pittsburgh, PA; Arthritis Research Center of Canada, University of British Columbia, Vancouver, British Columbia, Canada; University of Vermont College of Medicine; University of Vermont Breast Care Center, United Health Care, Burlington, VT; and the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA.</nlm:aff></affiliation></author><author><name sortKey="Anderson, Stewart J" sort="Anderson, Stewart J" uniqKey="Anderson S" first="Stewart J." last="Anderson">Stewart J. Anderson</name><affiliation><nlm:aff id="aff1">From the National Surgical Adjuvant Breast and Bowel Project Operations and Biostatistics Center; Graduate School of Public Health, University of Pittsburgh; Allegheny General Hospital, Pittsburgh, PA; Arthritis Research Center of Canada, University of British Columbia, Vancouver, British Columbia, Canada; University of Vermont College of Medicine; University of Vermont Breast Care Center, United Health Care, Burlington, VT; and the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA.</nlm:aff></affiliation></author><author><name sortKey="Krag, David N" sort="Krag, David N" uniqKey="Krag D" first="David N." last="Krag">David N. Krag</name><affiliation><nlm:aff id="aff1">From the National Surgical Adjuvant Breast and Bowel Project Operations and Biostatistics Center; Graduate School of Public Health, University of Pittsburgh; Allegheny General Hospital, Pittsburgh, PA; Arthritis Research Center of Canada, University of British Columbia, Vancouver, British Columbia, Canada; University of Vermont College of Medicine; University of Vermont Breast Care Center, United Health Care, Burlington, VT; and the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA.</nlm:aff></affiliation></author><author><name sortKey="Christian, Nicholas J" sort="Christian, Nicholas J" uniqKey="Christian N" first="Nicholas J." last="Christian">Nicholas J. Christian</name><affiliation><nlm:aff id="aff1">From the National Surgical Adjuvant Breast and Bowel Project Operations and Biostatistics Center; Graduate School of Public Health, University of Pittsburgh; Allegheny General Hospital, Pittsburgh, PA; Arthritis Research Center of Canada, University of British Columbia, Vancouver, British Columbia, Canada; University of Vermont College of Medicine; University of Vermont Breast Care Center, United Health Care, Burlington, VT; and the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA.</nlm:aff></affiliation></author><author><name sortKey="Costantino, Joseph P" sort="Costantino, Joseph P" uniqKey="Costantino J" first="Joseph P." last="Costantino">Joseph P. Costantino</name><affiliation><nlm:aff id="aff1">From the National Surgical Adjuvant Breast and Bowel Project Operations and Biostatistics Center; Graduate School of Public Health, University of Pittsburgh; Allegheny General Hospital, Pittsburgh, PA; Arthritis Research Center of Canada, University of British Columbia, Vancouver, British Columbia, Canada; University of Vermont College of Medicine; University of Vermont Breast Care Center, United Health Care, Burlington, VT; and the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA.</nlm:aff></affiliation></author><author><name sortKey="Wolmark, Norman" sort="Wolmark, Norman" uniqKey="Wolmark N" first="Norman" last="Wolmark">Norman Wolmark</name><affiliation><nlm:aff id="aff1">From the National Surgical Adjuvant Breast and Bowel Project Operations and Biostatistics Center; Graduate School of Public Health, University of Pittsburgh; Allegheny General Hospital, Pittsburgh, PA; Arthritis Research Center of Canada, University of British Columbia, Vancouver, British Columbia, Canada; University of Vermont College of Medicine; University of Vermont Breast Care Center, United Health Care, Burlington, VT; and the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA.</nlm:aff></affiliation></author><author><name sortKey="Ganz, Patricia A" sort="Ganz, Patricia A" uniqKey="Ganz P" first="Patricia A." last="Ganz">Patricia A. Ganz</name><affiliation><nlm:aff id="aff1">From the National Surgical Adjuvant Breast and Bowel Project Operations and Biostatistics Center; Graduate School of Public Health, University of Pittsburgh; Allegheny General Hospital, Pittsburgh, PA; Arthritis Research Center of Canada, University of British Columbia, Vancouver, British Columbia, Canada; University of Vermont College of Medicine; University of Vermont Breast Care Center, United Health Care, Burlington, VT; and the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA.</nlm:aff></affiliation></author></analytic><series><title level="j">Journal of Clinical Oncology</title><idno type="ISSN">0732-183X</idno><idno type="eISSN">1527-7755</idno><imprint><date when="2010">2010</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><sec><title>Purpose</title><p>Sentinel lymph node resection (SNR) may reduce morbidity while providing the same clinical utility as conventional axillary dissection (AD). National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32 is a randomized phase III trial comparing SNR immediately followed by AD (SNAD) to SNR and subsequent AD if SN is positive. We report the definitive patient-reported outcomes (PRO) comparisons.</p></sec><sec><title>Patients and Methods</title><p>Eligible patients had clinically node-negative, operable invasive breast cancer. The PRO substudy included all SN-negative participants enrolled May 2001 to February 2004 at community institutions in the United States (n = 749; 78% age ≥ 50; 87% clinical tumor size ≤ 2.0 cm; 84% lumpectomy; 87% white). They completed questionnaires presurgery, 1 and 2 to 3 weeks postoperatively, and every 6 months through year 3. Arm symptoms, arm use avoidance, activity limitations, and quality of life (QOL) were compared with intent-to-treat two-sample <italic>t</italic>-tests and repeated measures analyses.</p></sec><sec><title>Results</title><p>Arm symptoms were significantly more bothersome for SNAD compared with SNR patients at 6 months (mean, 4.8 <italic>v</italic> 3.0; <italic>P</italic> < .001) and at 12 months (3.6 <italic>v</italic> 2.5; <italic>P</italic> = .006). Longitudinally, SNAD patients were more likely to experience ipsilateral arm and breast symptoms, restricted work and social activity, and impaired QOL (<italic>P</italic> ≤ .002 all items). From 12 to 36 months, fewer than 15% of either SNAD or SNR patients reported moderate or greater severity of any given symptom or activity limitation.</p></sec><sec><title>Conclusion</title><p>Arm morbidity was greater with SNAD than with SNR. Despite considerable fears about complications from AD for breast cancer, this study demonstrates that initial problems with either surgery resolve over time.</p></sec></div></front></TEI><pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">J Clin Oncol</journal-id><journal-id journal-id-type="hwp">jco</journal-id><journal-id journal-id-type="pmc">jco</journal-id><journal-id journal-id-type="publisher-id">JCO</journal-id><journal-title-group><journal-title>Journal of Clinical Oncology</journal-title></journal-title-group><issn pub-type="ppub">0732-183X</issn><issn pub-type="epub">1527-7755</issn><publisher><publisher-name>American Society of Clinical Oncology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">20679600</article-id><article-id pub-id-type="pmc">2940391</article-id><article-id pub-id-type="publisher-id">82491</article-id><article-id pub-id-type="doi">10.1200/JCO.2010.28.2491</article-id><article-categories><subj-group subj-group-type="hwp-journal-coll"><subject>Bc3</subject><subject>Psc12</subject><subject>Psc13</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Reports</subject><subj-group><subject>Breast Cancer</subject></subj-group></subj-group></article-categories><title-group><article-title>Patient-Reported Outcomes in Sentinel Node–Negative Adjuvant Breast Cancer Patients Receiving Sentinel-Node Biopsy or Axillary Dissection: National Surgical Adjuvant Breast and Bowel Project Phase III Protocol B-32</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Land</surname><given-names>Stephanie R.</given-names></name><xref ref-type="aff" rid="aff1"></xref><xref ref-type="corresp" rid="cor1"></xref></contrib><contrib contrib-type="author"><name><surname>Kopec</surname><given-names>Jacek A.</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Julian</surname><given-names>Thomas B.</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Brown</surname><given-names>Ann M.</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Anderson</surname><given-names>Stewart J.</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Krag</surname><given-names>David N.</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Christian</surname><given-names>Nicholas J.</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Costantino</surname><given-names>Joseph P.</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Wolmark</surname><given-names>Norman</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Ganz</surname><given-names>Patricia A.</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib><aff id="aff1">From the National Surgical Adjuvant Breast and Bowel Project Operations and Biostatistics Center; Graduate School of Public Health, University of Pittsburgh; Allegheny General Hospital, Pittsburgh, PA; Arthritis Research Center of Canada, University of British Columbia, Vancouver, British Columbia, Canada; University of Vermont College of Medicine; University of Vermont Breast Care Center, United Health Care, Burlington, VT; and the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA.</aff></contrib-group><author-notes><corresp id="cor1">Corresponding author: Stephanie R. Land, PhD, Department of Biostatistics Graduate School of Public Health, National Surgical Adjuvant Breast and Bowel Project and University of Pittsburgh Cancer Institute University of Pittsburgh, 201 N Craig St, Suite 350, Pittsburgh, PA 15213; e-mail: <email>land@pitt.edu</email>.</corresp></author-notes><pub-date pub-type="ppub"><day>1</day><month>9</month><year>2010</year></pub-date><pub-date pub-type="epub"><day>2</day><month>8</month><year>2010</year></pub-date><pub-date pub-type="pmc-release"><day>1</day><month>9</month><year>2011</year></pub-date><pmc-comment> PMC Release delay is 12 months and 0 days and was based on the
<volume>28</volume><issue>25</issue><fpage>3929</fpage><lpage>3936</lpage><history><date date-type="received"><day>19</day><month>1</month><year>2010</year></date><date date-type="accepted"><day>2</day><month>6</month><year>2010</year></date></history><permissions><copyright-statement>© 2010 by American Society of Clinical Oncology</copyright-statement></permissions><self-uri xlink:title="pdf" xlink:type="simple" xlink:href="zlj02510003929.pdf"></self-uri><abstract><sec><title>Purpose</title><p>Sentinel lymph node resection (SNR) may reduce morbidity while providing the same clinical utility as conventional axillary dissection (AD). National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32 is a randomized phase III trial comparing SNR immediately followed by AD (SNAD) to SNR and subsequent AD if SN is positive. We report the definitive patient-reported outcomes (PRO) comparisons.</p></sec><sec><title>Patients and Methods</title><p>Eligible patients had clinically node-negative, operable invasive breast cancer. The PRO substudy included all SN-negative participants enrolled May 2001 to February 2004 at community institutions in the United States (n = 749; 78% age ≥ 50; 87% clinical tumor size ≤ 2.0 cm; 84% lumpectomy; 87% white). They completed questionnaires presurgery, 1 and 2 to 3 weeks postoperatively, and every 6 months through year 3. Arm symptoms, arm use avoidance, activity limitations, and quality of life (QOL) were compared with intent-to-treat two-sample <italic>t</italic>-tests and repeated measures analyses.</p></sec><sec><title>Results</title><p>Arm symptoms were significantly more bothersome for SNAD compared with SNR patients at 6 months (mean, 4.8 <italic>v</italic> 3.0; <italic>P</italic> < .001) and at 12 months (3.6 <italic>v</italic> 2.5; <italic>P</italic> = .006). Longitudinally, SNAD patients were more likely to experience ipsilateral arm and breast symptoms, restricted work and social activity, and impaired QOL (<italic>P</italic> ≤ .002 all items). From 12 to 36 months, fewer than 15% of either SNAD or SNR patients reported moderate or greater severity of any given symptom or activity limitation.</p></sec><sec><title>Conclusion</title><p>Arm morbidity was greater with SNAD than with SNR. Despite considerable fears about complications from AD for breast cancer, this study demonstrates that initial problems with either surgery resolve over time.</p></sec></abstract><funding-group><award-group><funding-source id="CS100">National Institutes of Health</funding-source></award-group></funding-group></article-meta></front></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002F37 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 002F37 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé=
|texte=
}}
| This area was generated with Dilib version V0.6.31. |  |